Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
V. Sadovici, L. Mazur-Nicorici, V. Salaru, T. Rotaru, S. Vetrila, M. Cebanu, M. Mazur (Chisinau, Republic Of Moldova). Do we need to screen for latent TB when initiating a methotrexate treatment?. Eur Respir J 2013; 42: Suppl. 57, 2839

Member's Comments

No comment yet.

Related content which might interest you: Tuberculosis and intravenous drug users, impact of proximity measures in screening and treatment Source: International Congress 2015 – Screening strategies in TB Year: 2015 Latent TB infection: Patient choices and completion of treatment Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 Is there a need for prolonged follow up in mono-drug resistant TB? Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Liver injury in treatment of latent tuberculosis infection - is the age cut-off for treatment justified? Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area Source: International Congress 2015 – Screening strategies in TB Year: 2015 Impact of social support programme on MDR-TB patients' treatment outcomes Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Recurrent TB in Ireland is predominantly due to relapsed infection and is frequently associated with poor compliance with therapy Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016 Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 The effectiveness of programmatic management of latent tuberculosis infection in the Netherlands Source: International Congress 2015 – Latent TB infection and screening Year: 2015 The European union standards for tuberculosis care: Do they need an update? Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 Preventive treatment for latent tuberculosis infection Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment Source: International Congress 2015 – Latent TB infection and screening Year: 2015 HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Is it necessary to give tuberculosis treatment daily throughout? Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014 Could side effects of MDR-TB treatment change the outcome of the disease? Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Prospects for early implementation of ambulatory treatment in XDR TB patients by optimizing the administration of linezolid at the intensive phase of chemotherapy Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Adherence to the recommendation of prescribing 4 drugs in the intensive phase of the standard treatment of tuberculosis in Spain Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Knowledge and attitude about tuberculosis disease in a health workers population Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Cohort analysis of a large community-based latent tuberculosis screening and treatment programme in a high incidence setting in East London Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016